TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
SMARCA4/BRG1-deficient lung adenocarcinoma (SD-LUAD) is being recognized as a distinct subtype based on subtle differences in its clinical, morphological, and immunophenotypic attributes compared to other non–small cell lung carcinomas. We present here a case of SD-LUAD with curious thyroid transcription factor 1 (TTF1) expression in a morphologically heterogenous lung adenocarcinoma. The better differentiated area showed preservation of TTF1 expression, and a poorly differentiated tumor had loss of TTF1 expression with universal BRG1 loss.
Abstract
SMARCA4/BRG1-deficient lung adenocarcinoma (SD-LUAD) is being recognized as a distinct subtype based on subtle differences in its clinical, morphological, and immunophenotypic attributes compared to other non–small cell lung carcinomas. We present here a case of SD-LUAD with curious thyroid transcription factor 1 (TTF1) expression in a morphologically heterogenous lung adenocarcinoma. The better differentiated area showed preservation of TTF1 expression, and a poorly differentiated tumor had loss of TTF1 expression with universal BRG1 loss.
참고문헌 (10)
- Kadoch C, "Proteomic and bioinformatic analysis of mammalian SWI", SNF complexes identifies extensive roles in human malignancy, 2013, pp.45, 592~601
- Errichiello E, "SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type", J Pathol, 243, pp.9~15 (2017)
- Herpel E, "SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer : immunohistochemical survey of 316 consecutive specimens", Ann Diagn Pathol, 26, pp.47~51 (2017)
- Agaimy A, "SMARCA4-deficient pulmonary adenocarcinoma : clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)", CK7(pos), Virchows Arch, pp.2017, 471[DOI]
- Anurag Mehta, "SMARCA4", BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non–small cell lung cancer, 2021, pp.55(5), 307~316[DOI]
- Nambirajan A, "SMARCA4", BRG1-deficient non-small cell lung carcinomas : a case series and review of the literature, 2021, pp.145, 90~98
- Naito T, "Non-small cell lung cancer with loss of expression of the SWI", SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden, 2019, pp.138, 35~42
- Oike T, "A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1", Cancer Res, 73, pp.5508~5518 (2013)
- Yoshida A, "Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities", Mod Pathol, 30, pp.797~809 (2017)
- Rekhtman N, "SMARCA4-deficient thoracic sarcomatoid tumors represent primarily smoking-related undifferentiated carcinomas rather than primary thoracic sarcomas", J Thorac Oncol, 15, pp.231~247 (2020)